Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Form Health is a telehealth platform that matches patients with prescribers for semaglutide and tirzepatide, charging monthly membership fees alongside medication costs. The platform gained popularity by simplifying access to GLP-1 medications with asynchronous provider oversight and flexible dosing protocols.

Choosing a GLP-1 program involves more than price and convenience—it requires understanding your individual physiology and how your body may respond to these medications. PlexusDx emphasizes precision-wellness evaluation, including genetic predisposition screening in peptide pathways, to support more informed conversations with your chosen provider.

How Form Health Structures Access and Provider Oversight

Form Health connects patients to licensed prescribers via an asynchronous telehealth model—meaning you submit health information and photos, a provider reviews it, and communication occurs via messaging rather than live video. This model reduces appointment friction but may limit real-time clinical discussion about your medical history or concurrent medications.

Providers on Form Health conduct baseline assessments, set initial dosing protocols, and monitor progress through submitted check-ins and weight updates. The platform handles prescription fulfillment and dose adjustments based on patient-reported tolerance and results, though individual provider communication depth varies.

Form Health Pricing, Medication Options, and Comparison Framework

Form Health charges a monthly membership fee plus the cost of the medication itself. Pricing varies by location and medication choice. Understanding the total cost structure—membership plus injections or oral formulations—helps you evaluate whether their model aligns with your budget and preference for provider interaction frequency.

Factor Form Health Model
Membership Fee Typically $99–$149/month depending on program tier
Medication Cost (Semaglutide) Varies; branded Wegovy or Rybelsus available through their network
Medication Cost (Tirzepatide) Varies; branded Mounjaro or Zepbound available through their network
Provider Interaction Model Asynchronous messaging; no scheduled video calls; providers adjust dosing based on submitted progress

Clinical Evidence Supporting Personalized GLP-1 Selection

Recent research shows GLP-1 response varies significantly among patients. Genetic variants in GLP1R, GIPR, FTO, and MC4R genes influence baseline metabolic rate, appetite-regulation sensitivity, and weight-loss trajectory on these medications. A 2023 review in Nature Metabolism noted up to 40% variability in weight-loss response between individuals on identical GLP-1 protocols.

This variability suggests that one-size-fits-all dosing or medication selection may not optimize outcomes for all patients. Understanding your genetic predispositions in these key pathways can help you and your provider align medication choice, starting dose, and titration pace with your individual biology.

Who Should Consider Form Health and What Questions to Ask Your Provider

Form Health suits patients who prefer asynchronous communication, live in areas with limited GLP-1 prescriber access, and are comfortable with messaging-based follow-up. However, if you have complex medical history, concurrent medications, or specific contraindications, live provider discussion before starting may be safer and more thorough.

Before enrolling in any GLP-1 program—whether Form Health or another—ask your provider whether genetic screening in peptide pathways would inform your medication selection. Questions about baseline kidney function, thyroid health, pancreatitis history, and medication interactions should always be addressed directly with a clinician, not via asynchronous chat alone.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context for how your body may respond to GLP-1 therapy by revealing predispositions in four key pathways: GLP1R (GLP-1 receptor sensitivity), GIPR (glucose-dependent insulinotropic peptide signaling), FTO (metabolic rate regulation), and MC4R (appetite control). This information should be interpreted with your qualified healthcare provider to inform medication selection and dosing strategy.

The genetic test does not predict your exact medication response or guarantee weight loss—genetics is one piece of a larger clinical picture that includes diet, activity, metabolism, and medical history. However, understanding your peptide genetic predispositions can support a more data-informed conversation with your provider about whether a GLP-1 like semaglutide or tirzepatide is appropriate for you, and at what starting dose.

Whether you choose Form Health, PlexusDx's compounded options, or another GLP-1 provider, integrating genetic context into your decision-making process may help you and your clinician select a medication and protocol better aligned with your individual biology. PlexusDx offers the Precision Peptide test as a standalone assessment ($298) or add-on to any compounded GLP-1 order ($99), enabling you to bring this data to any provider conversation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does Form Health require in-person appointments?

No. Form Health operates as a fully asynchronous telehealth platform. Patients submit health questionnaires, photos, and progress updates via messaging; providers review and adjust doses remotely without scheduled video calls.

What medications does Form Health offer?

Form Health provides access to semaglutide (Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) through partnered pharmacies. Specific medication availability may vary by location and provider.

How does Form Health pricing compare to PlexusDx compounded options?

Form Health charges membership plus branded medication costs, typically $200–$350/month total. PlexusDx compounded semaglutide starts at $149/mo and compounded tirzepatide at $249/mo, with no additional membership fee.

Are genetic predispositions in GLP-1 pathways reliable for predicting my response?

Genetic variants in GLP1R, GIPR, FTO, and MC4R inform your baseline metabolic and appetite biology but do not guarantee exact medication response. Clinical outcomes depend on genetics, lifestyle, compliance, and individual physiology combined. Discuss results with your provider.

How can I use a genetic test to choose between Form Health and compounded GLP-1s?

Genetic testing may reveal predispositions relevant to GLP-1 efficacy and side-effect tolerance, supporting a more informed provider conversation about whether branded or compounded semaglutide/tirzepatide suits you. PlexusDx Precision Peptide test ($298 standalone, $99 add-on) provides this context for any provider decision.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves